Skip to content

A prospective observational study on the safety and quality-of-life improvement effects of exercise therapy (Purple Edge Training) in breast cancer patients

A prospective observational study on the safety and quality-of-life improvement effects of exercise therapy (Purple Edge Training) in breast cancer patients - A prospective observational study on the safety and quality-of-life improvement effects of exercise therapy (Purple Edge Training) in breast cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059486
Enrollment
50
Registered
2025-10-27
Start date
2025-10-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

bioDensity: High-intensity, low-frequency, osteogenic loading (approximately 5 minutes) Power Plate: Whole-body vibration training (approximately 5 minutes) NEURONIC/RED LIGHT: Light therapy (about

Sponsors

BEYOND KAMPO Inc.
Lead Sponsor
Kochi Medical School Hospital
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Female (20 years of age or older) Patients with breast cancer who have undergone surgery, are undergoing treatment (ongoing or scheduled chemotherapy or endocrine therapy),or are in remission Patients who are able to visit the center and exercise on their own Patients who have received permission from their doctor to exercise Patients who have voluntarily agreed to participate in the study

Exclusion criteria

Exclusion criteria: Patients with conditions that contraindicate exercise, such as metastasis Patients who are deemed inappropriate by a doctor

Design outcomes

Primary

MeasureTime frame
Safety (incidence of adverse events), changes in bone mineral density, maximal voluntary force production, and Profile of Mood States 2nd edition (POMS2) score

Secondary

MeasureTime frame
Changes in breast cancer-specific QOL, sleep (AIS), etc. (If symptomatic) Pain (VAS), shoulder range of motion, lymphedema

Countries

Japan

Contacts

Public ContactRyuji Takasaki

BEYOND KAMPO Inc. Director

beyondkampo@gmail.com090-4803-2888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026